10 Biotech Stocks to Buy According to Matthew Strobeck's Birchview Capital
In this article, we discuss 10 biotech stocks to buy according to Matthew Strobeck's Birchview Capital.
Fund Name: | Birchview Capital |
Manager | Matthew Strobeck |
Portfolio Value | $127,549,846 |
Change This QTR | +1.09% |
Symbol | Company | Filed By | Filing Date | Filing |
---|---|---|---|---|
2024-02-20 | ||||
2023-04-07 | ||||
2023-02-13 | ||||
2022-12-15 | ||||
2021-12-17 |